Condition
Intensity-modulated Radiotherapy clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Intensity-modulated Radiotherapy clinical trials that are recruiting, in China. By phase: Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 1Country
Newest Intensity-modulated Radiotherapy clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Moderately hypofractionated radiotherapy after hysterectomy for cervical cancer | — | Beijing, Beijing Municipality and 1 other locations | Recruiting | Jul 6, 2026 |
| IMRT-only treatment for stage IB nasopharyngeal cancer without high-risk features | — | Fuzhou, Fujian | Recruiting | Jan 29, 2026 |
| Comparing endoscopic surgery and radiotherapy for early-stage nasopharyngeal cancer | — | Zhuhai, Guangdong | Recruiting | Aug 1, 2024 |
| Reducing radiation target volumes in nasopharyngeal carcinoma treatment | — | Zhongshan, Guangdong | Recruiting | Aug 16, 2023 |
| Preoperative intensity-modulated radiotherapy with concurrent anlotinib for localized extremity and trunk soft tissue sarcoma | Phase 2 | Beijing, Beijing Municipality | Recruiting | Dec 22, 2021 |
All recruiting trials (5)
-
Moderately hypofractionated radiotherapy after hysterectomy for cervical cancer
This study tests whether a shorter, moderately intensified radiotherapy course after surgery is safe and effective for patients with cervical cancer.
-
IMRT-only treatment for stage IB nasopharyngeal cancer without high-risk features
This trial will test whether IMRT alone can control stage IB nasopharyngeal cancer without high-risk features in adults aged 18–70.
-
Comparing endoscopic surgery and radiotherapy for early-stage nasopharyngeal cancer
This study is testing whether endoscopic surgery or radiotherapy works better for people with early-stage nasopharyngeal cancer and how each treatment affects their recovery.
-
Reducing radiation target volumes in nasopharyngeal carcinoma treatment
This study is testing if reducing the radiation area for patients with newly diagnosed nasopharyngeal cancer can improve their treatment outcomes and quality of life compared to the standard approach.
-
Preoperative intensity-modulated radiotherapy with concurrent anlotinib for localized extremity and trunk soft tissue sarcoma
This test combines preoperative IMRT and the drug anlotinib to see if it improves outcomes for adults with primary soft tissue sarcoma of the arms, legs, or trunk.
Related topics
Quick answers
How many Intensity-modulated Radiotherapy clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.